MeSH term
Frequency | Condition_Probility | Adolescent | 9 | 0.0 |
Chronic Disease | 24 | 1.0 |
Female | 23 | 0.0 |
Humans | 39 | 0.0 |
Male | 22 | 0.0 |
Adult | 16 | 0.0 |
Base Sequence | 6 | 0.0 |
DNA Mutational Analysis | 10 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Middle Aged | 14 | 0.0 |
Mutation | 8 | 0.0 |
Phenotype | 4 | 0.0 |
*Trypsin | 18 | 66.0 |
Trypsin Inhibitor, Kazal Pancreatic/*genetics | 9 | 47.0 |
Trypsinogen/*genetics | 13 | 92.0 |
Aged | 7 | 0.0 |
Cohort Studies | 4 | 0.0 |
Genetic Predisposition to Disease | 9 | 0.0 |
Genotype | 7 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
*Mutation | 7 | 0.0 |
Pancreatitis/etiology/*genetics | 3 | 75.0 |
Pancreatitis, Alcoholic/genetics | 2 | 100.0 |
Research Support, Non-U.S. Gov't | 28 | 0.0 |
Trypsinogen/genetics | 7 | 77.0 |
Case-Control Studies | 3 | 0.0 |
Child | 10 | 0.0 |
Child, Preschool | 4 | 0.0 |
Comparative Study | 5 | 0.0 |
Pancreatitis/diagnosis/*genetics | 3 | 50.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Probability | 2 | 0.0 |
Prognosis | 3 | 0.0 |
Severity of Illness Index | 2 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Mutation/*genetics | 8 | 0.0 |
Pancreatitis/*genetics | 17 | 48.0 |
Pedigree | 11 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Gene Conversion | 2 | 3.0 |
Mutation, Missense | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Kinetics | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Animals | 3 | 0.0 |
Exons | 2 | 0.0 |
Genetic Predisposition to Disease/genetics | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Trypsin/genetics | 2 | 100.0 |
Acute Disease | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Rats | 2 | 0.0 |
Rats, Inbred BN | 2 | 4.0 |
Risk Factors | 2 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
*Evolution, Molecular | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Age of Onset | 2 | 0.0 |
Cystic Fibrosis Transmembrane Conductance Regulator/genetics | 4 | 6.0 |
Trypsin Inhibitor, Kazal Pancreatic/genetics | 2 | 66.0 |
Heterozygote | 2 | 0.0 |
Genetic Predisposition to Disease/*genetics | 2 | 0.0 |
Cystic Fibrosis Transmembrane Conductance Regulator/*genetics | 3 | 2.0 |
Serine Proteinase Inhibitors/genetics | 2 | 22.0 |
Genetic Screening | 2 | 0.0 |
